Last reviewed · How we verify
Migraine without aura
Approved treatments
- Zavzpret · Pfizer
Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute migraine treatment. - Zavzpret · Pfizer
Zavzpret blocks the action of calcitonin gene-related peptide, a molecule involved in pain transmission.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Migraine without aura patent landscape — cliff calendar, originator estates, attackable patents
- Migraine without aura treatment landscape brief
- Migraine without aura treatment updates RSS
Frequently asked questions about Migraine without aura
What drugs treat Migraine without aura?
Tracked treatments include Zavzpret.
What is the treatment for Migraine without aura?
Standard treatment for Migraine without aura includes Zavzpret. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Migraine without aura patent cliff · Migraine without aura CI report
- Treatment: Zavzpret · Pfizer
- Treatment: Zavzpret · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing